SCHEMBL386768

SCHEMBL386768

O=C(OC(=O)C1CCCC1)C1CCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
ALDH1A1 P00352 2/20 0.40
TSHR P16473 1/20 0.40
POLB P06746 2/20 0.38
CHRM2 P08172 2/20 0.38
CHRM4 P08173 2/20 0.38
CHRM1 P11229 2/20 0.38
CHRM3 P20309 2/20 0.38
MIF P14174 1/20 0.37
ELANE P08246 1/20 0.37
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11862575 0.97 CES2 (0.55) CES2CES1SMN1; SMN2HTTKMT2A
SCHEMBL776566 0.97 CES2 (0.55) CES2CES1SMN1; SMN2HTTKMT2A
SCHEMBL27553353 0.97 CES2 (0.55) CES2CES1SMN1; SMN2HTTKMT2A
SCHEMBL248821 0.97 CES2 (0.55) CES2CES1SMN1; SMN2HTTKMT2A
SCHEMBL6939791 0.97 CES2 (0.55) CES2CES1SMN1; SMN2HTTKMT2A
SCHEMBL6113076 0.94 SMN1; SMN2 (0.52) CES2CES1SMN1; SMN2HTTKMT2A
SCHEMBL105221 0.90 KMT2A (0.40) CES2CES1SMN1; SMN2HTTKMT2A
Bicarbonate SCHEMBL7635343 0.88 SMN1; SMN2 (0.48) CES2CES1SMN1; SMN2HTTKMT2A
Propiolic Acid SCHEMBL28410793 0.85 CES2 (0.39) CES2CES1SMN1; SMN2HTTKMT2A
SCHEMBL2202711 0.84 CES2 (0.53) CES2CES1SMN1; SMN2HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119431466-A Environment-friendly synthesis method of cordycepin by taking inosine as raw material 深圳市倍昂生物科技有限公司 2025-02-14 CN claimed
CN-116606337-A Preparation method of cordycepin 上海素昂生物科技有限公司 2023-08-18 CN claimed
CN-116003503-A Preparation method of estradiol cyclopentanepropionate 湖北葛店人福药业有限责任公司 2023-04-25 CN claimed
CN-115887687-A Hyaluronic Acid (HA) -CA-4 conjugate and synthesis method and application thereof 广东省科学院动物研究所 2023-04-04 CN claimed
US-20200203711-A1 SILICON-BASED ENERGY STORAGE DEVICES WITH ANHYDRIDE CONTAINING ELECTROLYTE ADDITIVES ENEVATE CORPORATION 2020-06-25 US claimed
WO-2020132057-A1 SILICON-BASED ENERGY STORAGE DEVICES WITH ANHYDRIDE CONTAINING ELECTROLYTE ADDITIVES ENEVATE CORPORATION (US) 2020-06-25 WO claimed
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same DAIKIN INDUSTRIES, LTD. (JP) 2026-05-05 US disclosed
US-20250260063-A1 ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY DAIKIN INDUSTRIES, LTD. (JP) 2025-08-14 US disclosed
EP-3780232-B1 ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY BATTERY, AND MODULE DAIKIN IND LTD (JP) 2025-07-30 EP disclosed
CN-120077502-A Electrolyte, electrochemical device, secondary battery, and lithium ion secondary battery 大金工业株式会社 2025-05-30 CN disclosed
US-20250174720-A1 ELECTROLYTE, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE DAIKIN INDUSTRIES, LTD. (JP) 2025-05-29 US disclosed
US-12315885-B2 Electrolytic solution, electrochemical device, lithium-ion secondary battery, and module DAIKIN INDUSTRIES, LTD. (JP) 2025-05-27 US disclosed
EP-4553918-A1 NEGATIVE ELECTRODE, BATTERY, AND METHOD FOR COVERING BATTERY MATERIAL DAIKIN INDUSTRIES, LTD. (JP) 2025-05-14 EP disclosed
US-4959207-A ANHYDRIDE CONTAINING POLYMER OR MONOMER, COPPER COMPOUND NIPPON ZEON CO., LTD. (JP) 1990-09-25 US disclosed
US-4217362-A Anilide derivatives as antidepressants THE UPJOHN COMPANY (US) 1980-08-12 US disclosed
US-4212888-A Anilide derivatives as antidepressants THE UPJOHN COMPANY (US) 1980-07-15 US disclosed
US-4168248-A CONTAINING A METHYL NONANOL OR NONENOL OR ITS CARBOXYLIC ESTER FRITZSCHE DODGE & OLCOTT INC. (US) 1979-09-18 US disclosed
US-4128663-A Anilide derivatives as antidepressants THE UPJOHN COMPANY (US) 1978-12-05 US disclosed
US-3993675-A Process for the preparation of 1α,25-dihydroxycholecalciferol HOFFMANN-LA ROCHE INC. (US) 1976-11-23 US disclosed
US-3935166-A OR 2,7 NAPHTHALENE DICARBOXYLIC ACIDADHESIVE TEIJIN LIMITED (JA) 1976-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250174720-A1 ELECTROLYTE, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE HCN2, HCN1, HCN3 CES2 627/4885CES1 1303/4885SMN1; SMN2 1422/4885
US-12620622-B2 Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same ASH2L, OLA1, ODC1 CES2 2389/4885CES1 2196/4885SMN1; SMN2 1758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.